Higher intrinsic relapse activity and differential pharmacokinetics of natalizumab, which may possibly
High intrinsic relapse activity and differential pharmacokinetics of natalizumab, which may possibly take in between 3 and six months to wash out,10 and fingolimod, reported to significantly reduce CNS inflammation…